alimera sciences

September 28, 2009

Company Hopes Injectable Implant Cures Diabetic Macular Edema

Intraocular drug delivery systems are developing to treat diabetic macular edema. Sustained release systems offer hope of long term treatment, compliance and little or no side effects.
December 28, 2009

Iluvien® For Diabetic Macular Edema Has Eyes on FDA

Alimera's Iluvien proving effective in phase 3 clinical trials. Iluvien will release fluocinolone acetonide for the treatment of diabetic macular edema. Iluvien is an injectable extended release delivery system.
September 1, 2010

Iluvien Gets Closer to FDA for Diabetic Retinopathy

Iluvien is a type of drug delivery system that may be FDA approved for treating diabetic retinopathy. Instead of laser treatment, the eye will be injected.
September 30, 2010

Intraocular Drug Delivery Systems Gaining Momentum

Retinal specialists have been using intravitreal injections to treat retinal disease. Sustained release systems are gaining in popularity. Soon, more than retinal disease will be treated with these devices.